NYSE - Nasdaq Real Time Price USD
Alcon Inc. (ALC)
86.08 -0.19 (-0.22%)
As of 12:25:52 PM EST. Market Open.
Chart Range Bar
Loading chart for ALC
- Previous Close
86.27 - Open
87.55 - Bid 86.45 x 20000
- Ask 86.63 x 120000
- Day's Range
85.92 - 87.64 - 52 Week Range
71.55 - 99.20 - Volume
1,669,151 - Avg. Volume
1,543,480 - Market Cap (intraday)
42.445B - Beta (5Y Monthly) --
- PE Ratio (TTM)
40.99 - EPS (TTM)
2.10 - Earnings Date May 5, 2026
- Forward Dividend & Yield 0.33 (0.39%)
- Ex-Dividend Date May 14, 2025
- 1y Target Est
92.80
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
www.alcon.comRecent News: ALC
View More
Performance Overview: ALC
Trailing total returns as of 2/26/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
ALC
8.54%
MSCI WORLD (^990100-USD-STRD)
2.03%
1-Year Return
ALC
5.19%
MSCI WORLD (^990100-USD-STRD)
19.26%
3-Year Return
ALC
22.45%
MSCI WORLD (^990100-USD-STRD)
68.05%
5-Year Return
ALC
24.80%
MSCI WORLD (^990100-USD-STRD)
64.80%
Earnings Trends: ALC
View MoreAnalyst Insights: ALC
View MoreStatistics: ALC
View MoreValuation Measures
As of 2/25/2026
Market Cap
42.56B
Enterprise Value
46.41B
Trailing P/E
41.08
Forward P/E
23.20
PEG Ratio (5yr expected)
2.20
Price/Sales (ttm)
4.21
Price/Book (mrq)
1.78
Enterprise Value/Revenue
4.56
Enterprise Value/EBITDA
32.14
Financial Highlights
Profitability and Income Statement
Profit Margin
9.42%
Return on Assets (ttm)
2.75%
Return on Equity (ttm)
4.50%
Revenue (ttm)
10.4B
Net Income Avi to Common (ttm)
980M
Diluted EPS (ttm)
2.10
Balance Sheet and Cash Flow
Total Cash (mrq)
1.61B
Total Debt/Equity (mrq)
23.81%
Levered Free Cash Flow (ttm)
1.17B
Compare To: ALC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
246.80
-0.44%
Mkt Cap 17.775B
Industry Medical Instruments & Supplies
Company Insights: ALC
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports: ALC
View MoreAlcon Earnings: Decent Close to 2025 While Commercial Launches Expected To Tell 2026's Story
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
RatingPrice TargetM&A target may catalyze new phase of growth
Alcon Inc. is a global provider of ophthalmic surgery and vision care products. Founded in 1945 and based in Switzerland, Alcon previously operated as a subsidiary of Novartis AG. It became an independent company on April 9, 2019. The company has roughly 25,600 employees.
RatingPrice TargetU.S. stocks are fighting the good fight at midday on Friday, with tech stocks
U.S. stocks are fighting the good fight at midday on Friday, with tech stocks clawing back a bit of the steep losses seem in the past few sessions. Still, with any boost from earnings reports fading, an unsettled air is still in place as valuations remain a concern and now the future of interest rates is very much in doubt.
Alcon Earnings: Innovation Drives Solid Results and Reenergizes Investor Confidence
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
RatingPrice Target